Assignee
CELGENE AVILOMICS RES INC
US30 patents
Top patents by PatentIndex Score
US8609679B2Dec 17, 2013
2,4-diaminopyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC84 citations99
US9212181B2Dec 15, 2015
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC34 citations98
US9561228B2Feb 7, 2017
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC37 citations97
US8710222B2Apr 29, 2014
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC52 citations97
US9409921B2Aug 9, 2016
2,4-disubstituted pyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC25 citations94
US9296737B2Mar 29, 2016
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC27 citations94
US9409887B2Aug 9, 2016
Mutant-selective EGFR inhibitors and uses thereof
CELGENE AVILOMICS RES INC16 citations92
US9375431B2Jun 28, 2016
2,4-disubstituted pyrimidine compounds useful as kinase inhibtors
CELGENE AVILOMICS RES INC21 citations92
US9321786B2Apr 26, 2016
Heteroaryl compounds and uses thereof
CELGENE AVILOMICS RES INC15 citations92
US9145387B2Sep 29, 2015
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC21 citations92
US9458175B2Oct 4, 2016
MK2 inhibitors and uses thereof
CELGENE AVILOMICS RES INC16 citations91
US9504686B2Nov 29, 2016
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC10 citations84
US9040541B2May 26, 2015
4,6-disubstituted pyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC5 citations84
US8980935B2Mar 17, 2015
HCV protease inhibitors and uses thereof
CELGENE AVILOMICS RES INC7 citations84
US8748606B2Jun 10, 2014
4,6-diaminopyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC8 citations84
US9604936B2Mar 28, 2017
Besylate salt of a BTK inhibitor
CELGENE AVILOMICS RES INC13 citations83
US9540335B2Jan 10, 2017
Salts of an epidermal growth factor receptor kinase inhibitor
CELGENE AVILOMICS RES INC5 citations83
US9539255B2Jan 10, 2017
Solid forms of an epidermal growth factor receptor kinase inhibitor
CELGENE AVILOMICS RES INC6 citations83
US9108927B2Aug 18, 2015
Salts of an epidermal growth factor receptor kinase inhibitor
CELGENE AVILOMICS RES INC9 citations83
US9056839B2Jun 16, 2015
Solid forms of an epidermal growth factor receptor kinase inhibitor
CELGENE AVILOMICS RES INC9 citations83
US9415049B2Aug 16, 2016
Heteroaryl compounds and uses thereof
CELGENE AVILOMICS RES INC12 citations79
US9393246B2Jul 19, 2016
4,6-disubstituted pyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC3 citations73
US9067929B2Jun 30, 2015
Heterocyclic compounds and uses thereof
CELGENE AVILOMICS RES INC4 citations73
US9126950B2Sep 8, 2015
Heteroaryl compounds and uses thereof
CELGENE AVILOMICS RES INC4 citations68
US9422333B2Aug 23, 2016
HCV protease inhibitors and uses thereof
CELGENE AVILOMICS RES INC2 citations63
US9296704B2Mar 29, 2016
Substituted pyrimidines as protein kinase inhibitors
CELGENE AVILOMICS RES INC1 citations62
US10662195B2May 26, 2020
Protein kinase conjugates and inhibitors
CELGENE AVILOMICS RES INC1 citations61
US9549927B2Jan 24, 2017
Heteroaryl compounds and uses thereof
CELGENE AVILOMICS RES INC0 citations47
US9364476B2Jun 14, 2016
Methods of treating a Bruton's Tyrosine Kinase disease or disorder
CELGENE AVILOMICS RES INC1 citations43
US9492471B2Nov 15, 2016
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
CELGENE AVILOMICS RES INC0 citations36